Empowering Ovarian Cancer Patients: How to Educate and Support Those Starting ADC Therapy

Counseling Patients on ADC Side Effects Patient education is a cornerstone of successful ADC treatment. When introducing ADCs, providers focus on transparency—discussing the most common side effects upfront and reinforcing that many are reversible with dose holds or modifications. Eye toxicities and lung-related side effects like pneumonitis often cause anxiety. Clear communication and reassurance that these can be managed effectively help build trust. Educational materials and follow-up calls ensure patients feel supported and informed. Ultimately, the goal is to empower patients to report symptoms early and remain engaged in their care. ADC therapy offers significant clinical benefit, and with proactive management, patients can achieve extended survival and maintain their quality of life throughout treatment.

EP: 1.Managing Recurrent Ovarian Cancer: Tailoring Approaches Based on Platinum Sensitivity

EP: 2.The Role of Molecular Testing in Ovarian Cancer Care

EP: 3.From Challenges to Solutions: Ensuring Timely and Effective Molecular Testing in Ovarian Cancer

EP: 4.Mirvetuximab Soravtansine in Ovarian Cancer: Clinical Perspectives and Key Insights from MIRASOL

EP: 5.Advances in ADC Therapy for Ovarian Cancer

EP: 6.Making the Most of ADCs: Balancing Benefits and Managing Concerns in Ovarian Cancer

EP: 7.Patient Case Presentation: 65-year-old woman with platinum-resistant ovarian cancer

EP: 8.Ocular AE Management in Ovarian Cancer: Coordination Between Oncology and Eye Care Teams

EP: 9.Expert Perspectives and Best Practices for Managing Ocular Adverse Events in Ovarian Cancer

Now Viewing

EP: 10.Empowering Ovarian Cancer Patients: How to Educate and Support Those Starting ADC Therapy

Counseling Patients on ADC Side Effects

Patient education is a cornerstone of successful ADC treatment. When introducing ADCs, providers focus on transparency—discussing the most common side effects upfront and reinforcing that many are reversible with dose holds or modifications.

Eye toxicities and lung-related side effects like pneumonitis often cause anxiety. Clear communication and reassurance that these can be managed effectively help build trust. Educational materials and follow-up calls ensure patients feel supported and informed.

Ultimately, the goal is to empower patients to report symptoms early and remain engaged in their care. ADC therapy offers significant clinical benefit, and with proactive management, patients can achieve extended survival and maintain their quality of life throughout treatment.

Recent Videos